Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Nora Lovas"'
Autor:
Sarolta Nahajevszky, Hajnalka Andrikovics, Arpad Batai, Emma Adam, Andras Bors, Judit Csomor, Laszlo Gopcsa, Magdalena Koszarska, Andras Kozma, Nora Lovas, Sandor Lueff, Zoltan Matrai, Nora Meggyesi, Janos Sinko, Andrea Sipos, Andrea Varkonyi, Sandor Fekete, Attila Tordai, Tamas Masszi
Publikováno v:
Haematologica, Vol 96, Iss 11 (2011)
Background Prognostic risk stratification according to acquired or inherited genetic alterations has received increasing attention in acute myeloid leukemia in recent years. A germline Janus kinase 2 haplotype designated as the 46/1 haplotype has bee
Externí odkaz:
https://doaj.org/article/ac88012fc4f3488ab632138d40c784fc
Autor:
Petra Kövy, Zoltán Őrfi, András Bors, András Kozma, László Gopcsa, János Dolgos, Nóra Lovas, József Harasztdombi, Viktor Lakatos, Ágnes Király, Gábor Mikala, István Vályi-Nagy, Péter Reményi, Hajnalka Andrikovics
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0253386 (2021)
Monitoring measurable residual disease (MRD) in acute myeloid leukemia (AML) plays an important role in predicting relapse and outcome. The applicability of the leukemia-initiating nucleophosmin1 (NPM1) gene mutations in MRD detection is well-establi
Externí odkaz:
https://doaj.org/article/a29c4b9b870e4ce6a27101d22d6b7a81